BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23942606)

  • 1. Liver failure after major liver resection: risk assessment by using preoperative Gadoxetic acid-enhanced 3-T MR imaging.
    Wibmer A; Prusa AM; Nolz R; Gruenberger T; Schindl M; Ba-Ssalamah A
    Radiology; 2013 Dec; 269(3):777-86. PubMed ID: 23942606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of postoperative liver failure using gadoxetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
    Jin YJ; Lee SH; Cho SG; Kim JH; Lee JW; Lee KY; Shin WY
    J Gastroenterol Hepatol; 2016 Jul; 31(7):1349-56. PubMed ID: 26916616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of gadoxetate disodium-enhanced MR imaging for predicting posthepatectomy liver failure after major hepatic resection: a preliminary study.
    Cho SH; Kang UR; Kim JD; Han YS; Choi DL
    Eur J Radiol; 2011 Nov; 80(2):e195-200. PubMed ID: 21908121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive differentiation of simple steatosis and steatohepatitis by using gadoxetic acid-enhanced MR imaging in patients with nonalcoholic fatty liver disease: a proof-of-concept study.
    Bastati N; Feier D; Wibmer A; Traussnigg S; Balassy C; Tamandl D; Einspieler H; Wrba F; Trauner M; Herold C; Ba-Ssalamah A
    Radiology; 2014 Jun; 271(3):739-47. PubMed ID: 24576046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can contrast-enhanced MRI with gadoxetic acid predict liver failure and other complications after major hepatic resection?
    Costa AF; Tremblay St-Germain A; Abdolell M; Smoot RL; Cleary S; Jhaveri KS
    Clin Radiol; 2017 Jul; 72(7):598-605. PubMed ID: 28274510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker.
    Choi JW; Lee JM; Kim SJ; Yoon JH; Baek JH; Han JK; Choi BI
    Radiology; 2013 Jun; 267(3):776-86. PubMed ID: 23401584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.
    Ahn SS; Kim MJ; Lim JS; Hong HS; Chung YE; Choi JY
    Radiology; 2010 May; 255(2):459-66. PubMed ID: 20413759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Posthepatectomy Liver Failure: MRI With Hepatocyte-Specific Contrast Agent Versus Indocyanine Green Clearance Test.
    Kim DK; Choi JI; Choi MH; Park MY; Lee YJ; Rha SE; Jung SE
    AJR Am J Roentgenol; 2018 Sep; 211(3):580-587. PubMed ID: 29995498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hilar cholangiocarcinoma: value of adding DW imaging to gadoxetic acid-enhanced MR imaging with MR cholangiopancreatography for preoperative evaluation.
    Park MJ; Kim YK; Lim S; Rhim H; Lee WJ
    Radiology; 2014 Mar; 270(3):768-76. PubMed ID: 24475800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images.
    Kang Y; Lee JM; Kim SH; Han JK; Choi BI
    Radiology; 2012 Sep; 264(3):751-60. PubMed ID: 22798225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns.
    Park MJ; Kim YK; Lee MW; Lee WJ; Kim YS; Kim SH; Choi D; Rhim H
    Radiology; 2012 Sep; 264(3):761-70. PubMed ID: 22843769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-hepatectomy liver failure after major hepatic surgery: not only size matters.
    Asenbaum U; Kaczirek K; Ba-Ssalamah A; Ringl H; Schwarz C; Waneck F; Fitschek F; Loewe C; Nolz R
    Eur Radiol; 2018 Nov; 28(11):4748-4756. PubMed ID: 29767320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation.
    Tsuboyama T; Onishi H; Kim T; Akita H; Hori M; Tatsumi M; Nakamoto A; Nagano H; Matsuura N; Wakasa K; Tomoda K
    Radiology; 2010 Jun; 255(3):824-33. PubMed ID: 20501720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC.
    Kim YK; Lee WJ; Park MJ; Kim SH; Rhim H; Choi D
    Radiology; 2012 Oct; 265(1):104-14. PubMed ID: 22891358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
    Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
    Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI.
    Suh YJ; Kim MJ; Choi JY; Park YN; Park MS; Kim KW
    AJR Am J Roentgenol; 2011 Jul; 197(1):W44-52. PubMed ID: 21700994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Orthotopic Liver Transplant Graft Survival on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Using Qualitative and Quantitative Parameters.
    Bastati N; Wibmer A; Tamandl D; Einspieler H; Hodge JC; Poetter-Lang S; Rockenschaub S; Berlakovich GA; Trauner M; Herold C; Ba-Ssalamah A
    Invest Radiol; 2016 Nov; 51(11):728-734. PubMed ID: 27175548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging.
    Sourbron S; Sommer WH; Reiser MF; Zech CJ
    Radiology; 2012 Jun; 263(3):874-83. PubMed ID: 22623698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.